FR941104-2-00042 FR941104-2-00029 4. Transmittal of Periodic Reports and Promotional Material for New Animal Drugs_0910&hyph;0019 (Reinstatement)_These records and reports are used to facilitate a determination as to whether there may be grounds for suspending or withdrawing approval of the application, or whether any applicable regulation should be amended or repealed. The respondents are the sponsors of approved New Animal Drugs Applications whose numbers have increased over the years. Respondents: Businesses or other for-profit. ␣ 1Title 1No. of respondents 1No. of responses per respondent 1Average burden per response (hours) Reporting, 21 CFR 510.302(a) 1,500 2.3 .5 Recordkeeping, 21 CFR 510.300(a) 1,500 1 10.35 Estimated Total Annual Burden .␣.␣. 17,275 hours. Written comments and recommendations concerning the proposed information collections should be sent within 30 days of this notice directly to the OMB Desk Officer designated below at the following address: Shannah Koss, Human Resources and Housing Branch, New Executive Office Building, room 10235, Washington, DC 20503. Dated: October 27, 1994. James Scanlon, Director, Division of Data Policy, Office of Health Planning and Evaluation. [FR Doc. 94&hyph;27269 Filed 11&hyph;3&hyph;94; 8:45 am] BILLING CODE 4160&hyph;17&hyph;M
